A preliminary, randomized, multicenter study comparing intravenous immunoglobulin, plasma exchange, and immune adsorption in Guillain-Barré syndrome

Eur Neurol. 2001;46(2):107-9. doi: 10.1159/000050777.

Authors

H C Diener¹, W F Haupt, T M Kloss, F Rosenow, T Philipp, S Koeppen, A Vietorisz; Study Group

Affiliation

¹ Department of Neurology, University of Essen, Hufelandstrasse 55, D-45147 Essen, Germany. h.diener@uni-essen.de

PMID: 11528165
DOI: 10.1159/000050777

No abstract available

Publication types

Clinical Trial
Clinical Trial, Phase III
Comparative Study
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Cause of Death
Female
Germany
Guillain-Barre Syndrome / mortality
Guillain-Barre Syndrome / therapy*
Humans
Immunoglobulins, Intravenous / adverse effects
Immunoglobulins, Intravenous / therapeutic use*
Immunosorbent Techniques* / adverse effects
Infusions, Intravenous
Male
Middle Aged
Neurologic Examination
Plasma Exchange* / adverse effects
Prospective Studies
Survival Rate
Treatment Outcome

Substances

Immunoglobulins, Intravenous